NCT06076616

Brief Summary

Prehabilitation and rehabilitation through personalized lifestyle counseling in patients with breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2022

Completed
10 months until next milestone

First Posted

Study publicly available on registry

October 11, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

December 6, 2022

Last Update Submit

May 14, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Recruitment/consent rate

    To estimate patient recruitment/consent rate to the prehabilitation/rehabilitation group Enrolment logs will be recorded for all patients who meet the eligibility criteria. Reasons for non-participation will be recorded. We define a success criterion of 40% of the total number of participants invited to be recruited to the pilot study.

    From baseline to 6 months postoperatively

  • Attendance rate

    To estimate patient attendance, measured by the number of sessions attended out of 10. Reasons for non-attendance will be collected and withdrawals tracked. We will consider an attendance rate of 80% satisfactory

    From baseline to 6 months postoperatively

  • Patient adherence

    To estimate patient adherence monitored with the aid of the wearables. Adherence is defined as at least 150 min of moderate intensity exercise and at least two strength training sessions per week. Exercise instructions are based on the Health Council's exercise guidelines. We will consider an adherence of 70% as satisfactory.

    From baseline to 6 months postoperatively

  • Withdrawals

    To estimate the number of withdrawals, defined as the proportion of patients who quit the intervention before reaching the primary endpoint (HRQOL at six months after surgery). Information about the reasons for withdrawal will be collected.

    From baseline to 6 months postoperatively

  • Patient satisfaction

    To estimate patient satisfaction with the programme assessed during three interviews: at four weeks, at three months after surgery and at the end of the study. Satisfaction is defined as: satisfaction with the lifestyle coach, satisfaction with the duration of the intervention, satisfaction with the physical training programme. Patients will be given room for their own input to improve the intervention.

    From baseline to 6 months postoperatively

  • Selection bias

    To explore any evidence of selection bias in participants recruited into the study (assessed through participant characteristics at baseline).

    From baseline to 6 months postoperatively

Secondary Outcomes (10)

  • Likely changes in Health Related Quality of Life (HRQOL)

    Baseline, the day before surgery, 6 months postoperatively

  • Likely changes in BMI

    Baseline, the day before surgery, 6 months postoperatively

  • Likely changes in functional capacity (physical fitness)

    Baseline, the day before surgery, 6 months postoperatively

  • Likely changes in the number of postoperative complications

    30 days after surgery

  • Likely changes in smoking status

    Measured at baseline and 6 months postoperatively

  • +5 more secondary outcomes

Study Arms (2)

Prehabilitation/rehabilitation

EXPERIMENTAL

Patients in this arm follow a lifestyle counseling programme starting from diagnosis up to 6 months postoperatively.

Behavioral: Prehabilitation and rehabilitation

Usual care

NO INTERVENTION

Patients in this arm follow usual care.

Interventions

A personalized lifestyle counseling programme.

Prehabilitation/rehabilitation

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman with a confirmed breast cancer diagnosis
  • Planned surgical treatment of breast cancer
  • Age 18 years or older
  • Provision of written informed consent

You may not qualify if:

  • Severe mental retardation, which limits the ability to follow instructions independently
  • Severe psychiatric problems, which limits the ability to follow instructions independently
  • Legal incapacity
  • Language barrier: If we cannot find a lifestyle coach who speaks the patient's language, unfortunately we cannot offer the lifestyle coaching in its entirety, and this option will be omitted for the patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Franciscus Gasthuis en Vlietland

Rotterdam, South Holland, 3045PM, Netherlands

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Preoperative ExerciseRehabilitation

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Perioperative CarePatient CareTherapeuticsSurgical Procedures, OperativeExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth ServicesHealth Care Facilities Workforce and ServicesAftercareContinuity of Patient Care

Study Officials

  • Taco Klem, MD,PHD

    Franciscus Gasthuis & Vlietland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A pilot study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2022

First Posted

October 11, 2023

Study Start

December 1, 2022

Primary Completion

December 1, 2023

Study Completion

January 1, 2024

Last Updated

May 16, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations